Lifeward Ltd. Appoints Larry Jasinski as CEO to Drive Growth and Expansion; Co-founder Brian Harris Becomes Chief Scientific Officer

Reuters
07 Jul
<a href="https://laohu8.com/S/LFWD">Lifeward Ltd</a>. Appoints Larry Jasinski as CEO to Drive Growth and Expansion; Co-founder Brian Harris Becomes Chief Scientific Officer

Lifeward Ltd. has appointed Larry Jasinski as the new Chief Executive Officer of MedRhythms, effective immediately. Jasinski, an industry veteran with over 30 years of experience in the medical device and neurotechnology sectors, will lead the company into its next phase of growth and commercial expansion. Co-founder Brian Harris will transition to the role of Chief Scientific Officer to support the company's mission and market growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE24211) on July 07, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10